"Rokotetutkimuskeskus on Tampereen yliopiston lääketieteen ja terveysteknologian tiedekunnan alaisuudessa toimiva erikoisyksikkö. Toteutamme tieteellisesti ja eettisesti korkeatasoisia, kliinisiä rokotetutkimuksia yhdessä rokotevalmistajien kanssa, sekä omia akateemisia tutkimushankkeita. Tavoitteemme on saada käyttöön uusia, entistä turvallisempia ja tehokkaampia rokotteita lapsille, nuorille ja aikuisille. Rokotetutkimuskeskusta johtaa professori Mika Rämet."

During the past decade, Turku Vaccine Research Clinic conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 15 clinical trials were completed, i.e. on average, 107.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Turku Vaccine Research Clinic" #1 sponsor was "Pfizer" with 14 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Novartis Vaccines" with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Turku Vaccine Research Clinic" are "Meningococcal Vaccine" (4 trials), "Infections, Meningococcal" (2 trials), "Pneumococcal Infections" (2 trials), "Clostridium Difficile Infection" (1 trials) and "Hepatitis B Vaccines" (1 trials). Many other conditions were trialed in "Turku Vaccine Research Clinic" in a lesser frequency.

Most popular intervention types in "Turku Vaccine Research Clinic" are "Biological" (19 trials), "Drug" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Nimenrix" (2 trials), "RSVpreF" (2 trials), "Saline" (2 trials) and "rLP2086" (2 trials). Other intervention names were less common.

The vast majority of trials in "Turku Vaccine Research Clinic" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Turku Vaccine Research Clinic". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Turku Vaccine Research Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Turku Vaccine Research Clinic, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".